Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
2020Letter to the editor: Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma
Watz, H.; Hohlfeld, J.M.; Singh, D.; Beier, J.; Diamant, Z.; Liu, J.; Hua, S.; Abd-Elaziz, K.; Pinot, P.; Jones, I.; Tillmann, H.-C.
Zeitschriftenaufsatz
2019The Combination of Indacaterol/Glycopyrronium/Mometasone Furoate Is Superior to High-Dose Salmeterol/Fluticasone Propionate in Improving Lung Function in Patients with Asthma
Watz, H.; Hohlfeld, J.M.; Singh, D.; Beier, J.; Scholz, V.; Diamant, Z.; Liu, J.; Hua, S.; Pinot, P.; Jones, I.; Sarkar, A.; Tillmann, H.
Abstract
2019The Effect of Tiotropium/Olodaterol versus Salmeterol/Fluticasone on Left Ventricular Function and Lung Hyperinflation in Patients with COPD
Herth, F.J.; Hohlfeld, J.M.; Haas, J.; Hoz, A. de la; Jin, X.; Kreitner, K.; Vogelmeier, C.F.; Vogel-Claussen, J.; Watz, H.
Abstract
2019The Efficacy of the Combination Indacaterol/Glycopyrronium/Mometasone Furoate Is Independent of Time of Dosing in Patients with Asthma
Beier, J.; Watz, H.; Scholz, V.; Diamant, Z.; Hohlfeld, J.M.; Singh, D.; Pinot, P.; Lheritier, K.; Sarkar, A.; Tillmann, H.
Abstract
2019Rating sputum cell quality in clinical trials for asthma and COPD treatment
Pedersen, Frauke; Zissler, Ulrich M.; Watz, Henrik; Rabe, Klaus F.; Hohlfeld, Jens M.; Holz, Olaf
Zeitschriftenaufsatz
2018A comprehensive way to rate sputum quality in clinical trials
Pedersen, Frauke; Zissler, U.; Watz, Henrik; Rabe, Klaus F.; Hohlfeld, Jens M.; Holz, Olaf
Abstract
2018A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: A feasibility randomized clinical trial
Greulich, Timm; Hohlfeld, Jens M.; Neuser, Petra; Lueer, Katrin; Klemmer, Andreas; Schade-Brittinger, Carmen; Harnisch, Susanne; Garn, Holger; Renz, Harald; Homburg, Ursula; Renz, Jonas; Kirsten, Anne; Pedersen, Frauke; Müller, Meike; Vogelmeier, Claus F.; Watz, Henrik
Zeitschriftenaufsatz
2017Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
Waschki, Benjamin; Watz, Henrik; Holz, Olaf; Magnussen, Helgo; Olejnicka, Beata; Welte, Tobias; Rabe, Klaus F.; Janciauskiene, Sabina
Zeitschriftenaufsatz
2016α1-Antitrypsin (a1at) serum levels as marker of systemic inflammation in non-A1at-deficient patients with COPD
Waschki, B.; Kirsten, A.-M.; Holz, O.; Meyer, T.; Lichtinghagen, R.; Rabe, K.F.; Magnussen, H.; Welte, T.; Watz, H.; Janciauskiene, S.
Abstract
2016Angiopoietin-like protein 4 and cardiovascular function in COPD
Waschki, Benjamin; Kirsten, Anne-Marie; Holz, Olaf; Meyer, T.; Lichtinghagen, R.; Rabe, K.F.; Magnussen, Helgo; Welte, T.; Watz, H.; Janciauskiene, S.
Zeitschriftenaufsatz
2015Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD
Holz, Olaf; Roepcke, Stefan; Watz, Henrik; Tegtbur, Uwe; Lahu, Gezim; Hohlfeld, Jens Michael
Zeitschriftenaufsatz
2015Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease
Waschki, Benjamin; Kirsten, Anne M.; Holz, Olaf; Müller, Kai-Christian; Schaper, Miriam; Sack, Anna-Lena; Meyer, Thorsten; Rabe, Klaus F.; Magnussen, Helgo; Watz, Henrik
Zeitschriftenaufsatz
2015Multi-analyte profiling of inflammatory mediators in COPD sputum - The effects of processing
Pedersen, Frauke; Holz, Olaf; Lauer, Gereon; Quintini, Gianluca; Kiwull-Schöne, Heidrun; Kirsten, Anne-Marie; Magnussen, Helgo; Rabe, Klaus F.; Goldmann, Torsten; Watz, Henrik
Zeitschriftenaufsatz
2015Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients
Pedersen, Frauke; Marwitz, Sebastian; Holz, Olaf; Kirsten, Anne; Bahmer, Thomas; Waschki, Benjamin; Magnussen, Helgo; Rabe, Klaus F.; Goldmann, Torsten; Uddin, Mohib; Watz, Henrik
Zeitschriftenaufsatz
2015The role of sustained physical inactivity in the progression of exercise intolerance and muscle depletion in COPD
Waschki, B.; Kirsten, A.; Holz, O.; Müller, K.C.; Schaper, M.; Sack, A.L.; Meyer, T.; Rabe, K.; Magnussen, H.; Watz, H.
Abstract
2014Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table
Kornmann, Oliver; Watz, Henrik; Fuhr, Rainard; Krug, Norbert; Erpenbeck, Veit J.; Kaiser, Guenther
Zeitschriftenaufsatz
2014Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD
Holz, Olaf; Waschki, Benjamin; Roepcke, Stefan; Watz, Henrik; Lauer, Gereon; Faulenbach, Cornelia; Hohlfeld, Jens M.
Zeitschriftenaufsatz
2013The anti-IL-17A antibody secukinumab does not attenuate ozone-induced airway neutrophilia in healthy volunteers
Kirsten, A.; Watz, H.; Pedersen, F.; Holz, O.; Smith, R.; Bruin, G.; Koehne-Voss, S.; Magnussen, H.; Waltz, D.A.
Zeitschriftenaufsatz
2012Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of desease severity
Cockayne, Debra A.; Cheng, Donovan T.; Waschki, Benjamin; Sridhar, Sriram; Ravindran, Palanikumar; Hilton, Holly; Kourteva, Galina; Bitter, Hans; Pillai, Sreekumar G.; Visvanathan, Sudha; Müller, Kai-Christian; Holz, Olaf; Magnussen, Helgo; Watz, Henrik; Fine, Jay S.
Zeitschriftenaufsatz